HealthStream (HSTM) 10-Q 29 Oct 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 23, 2013
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	30-Sep-13
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Entity Registrant Name	HEALTHSTREAM INC
Entity Central Index Key	1095565
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		27,256,598

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$55,103	$41,365
Marketable securities - short-term	49,592	51,952
Accounts receivable, net of allowance for doubtful accounts of $210 and $142 at September 30, 2013 and December 31, 2012, respectively	22,741	15,348
Accounts receivable - unbilled	1,219	1,163
Deferred tax assets, current	549	2,459
Prepaid royalties, net of amortization	8,248	3,738
Other prepaid expenses and other current assets	3,196	2,266
Total current assets	140,648	118,291
Property and equipment:
Equipment	20,193	18,108
Leasehold improvements	5,161	5,050
Furniture and fixtures	3,622	3,368
Property and equipment, gross	28,976	26,526
Less accumulated depreciation and amortization	-21,106	-18,706
Total, property and equipment	7,870	7,820
Capitalized software development, net of accumulated amortization of $13,152 and $10,987 at September 30, 2013 and December 31, 2012, respectively	10,584	9,732
Goodwill	34,044	29,299
Intangible assets, net of accumulated amortization of $11,160 and $10,036 at September 30, 2013 and December 31, 2012, respectively	10,831	8,805
Other assets	824	581
Total assets	204,801	174,528
Current liabilities:
Accounts payable	1,848	1,057
Accrued liabilities	7,551	4,671
Accrued royalties	8,074	5,037
Accrued compensation and related expenses	1,548	1,121
Deferred revenue	35,326	23,146
Total current liabilities	54,347	35,032
Deferred tax liabilities, noncurrent	6,555	6,474
Other long term liabilities	643	826
Commitments and contingencies
Shareholders' equity:
Common stock, no par value, 75,000 shares authorized; 27,242 and 26,233 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	162,469	158,020
Accumulated deficit	-19,184	-25,842
Accumulated other comprehensive income (loss)	-29	18
Total shareholders' equity	143,256	132,196
Total liabilities and shareholders' equity	$204,801	$174,528

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Statement Of Financial Position [Abstract]
Allowance for doubtful accounts, net	$210	$142
Accumulated amortization on capitalized software development	13,152	10,987
Accumulated amortization on intangible assets	$11,160	$10,036
Common stock, no par value
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	27,242	26,233
Common stock, shares outstanding	27,242	26,233

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Revenues, net	$33,659	$26,380	$95,224	$75,894
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization)	14,092	10,804	39,483	30,546
Product development	3,210	2,278	8,594	6,328
Sales and marketing	5,888	4,423	16,538	14,637
Other general and administrative expenses	4,551	3,472	13,640	9,491
Depreciation and amortization	2,039	1,672	5,812	4,779
Total operating costs and expenses	29,780	22,649	84,067	65,781
Income from operations	3,879	3,731	11,157	10,113
Other income, net	46	42	121	87
Income before income tax provision	3,925	3,773	11,278	10,200
Income tax provision	1,629	1,796	4,620	4,376
Net income	$2,296	$1,977	$6,658	$5,824
Earnings per share:
Basic	$0.08	$0.08	$0.25	$0.22
Diluted	$0.08	$0.07	$0.24	$0.21
Weighted average shares of common stock outstanding:
Basic	27,085	26,173	26,716	26,100
Diluted	27,735	27,591	27,598	27,476

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Statement Of Income And Comprehensive Income [Abstract]
Net income	$2,296	$1,977	$6,658	$5,824
Other comprehensive income, net of taxes:
Unrealized gain (loss) on marketable securities	6	25	-47	35
Total other comprehensive income (loss)	6	25	-47	35
Comprehensive income	$2,302	$2,002	$6,611	$5,859

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Shareholders' Equity (USD $)	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
In Thousands
Beginning balance at Dec. 31, 2012	$132,196	$158,020	($25,842)	$18
Beginning balance, shares at Dec. 31, 2012		26,233
Net income	6,658		6,658
Comprehensive loss	-47			-47
Stock based compensation	1,088	1,088
Issuance of common stock in acquisition	534	534
Issuance of common stock in acquisition, shares		15
Tax benefits from equity awards	-72	-72
Common stock issued under stock plans, net of shares withheld for employee taxes	2,899	2,899
Common stock issued under stock plans, net of shares withheld for employee taxes, shares		994
Ending balance at Sep. 30, 2013	$143,256	$162,469	($19,184)	($29)
Ending balance, shares at Sep. 30, 2013		27,242

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
OPERATING ACTIVITIES:
Net income	$6,658	$5,824
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,812	4,779
Stock based compensation expense	1,088	837
Deferred income taxes	4,560	4,200
Excess tax benefits from equity awards	72
Loss on other investments	30
Provision for doubtful accounts	95	70
Changes in operating assets and liabilities:
Accounts and unbilled receivables	-7,312	451
Prepaid royalties	-4,509	1,568
Other prepaid expenses and other current assets and other assets	281	94
Accounts payable	792	-2,031
Accrued liabilities and accrued compensation and related expenses and other long-term liabilities	346	-767
Accrued royalties	3,037	-191
Deferred revenue	11,904	768
Net cash provided by operating activities	22,854	15,602
INVESTING ACTIVITIES:
Acquisitions, net of cash acquired	-7,362	-2,904
Proceeds from maturities of investments in marketable securities	63,722	35,125
Proceeds from sales of investments in marketable securities	5,062
Purchases of investments in marketable securities	-67,634	-95,283
Changes in other investments	-300	-250
Payments associated with capitalized software development	-3,017	-3,097
Purchases of property and equipment	-2,414	-3,185
Net cash used in investing activities	-11,943	-69,594
FINANCING ACTIVITIES:
Proceeds from exercise of stock options	3,057	791
Excess tax benefits from equity awards	-72
Taxes paid related to net settlement of equity awards	-158
Net cash provided by financing activities	2,827	791
Net increase (decrease) in cash and cash equivalents	13,738	-53,201
Cash and cash equivalents at beginning of period	41,365	76,904
Cash and cash equivalents at end of period	55,103	23,703
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock in connection with acquisitions	$534	$575

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]
Basis of Presentation	1. BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, condensed consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated in consolidation. Operating results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.
	The balance sheet at December 31, 2012 is consistent with the audited financial statements at that date but does not include all of the information and footnotes required by US GAAP for a complete set of financial statements. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended December 31, 2012 (included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 1, 2013).

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]
Income Taxes	2. INCOME TAXES
	Income taxes are accounted for using the asset and liability method, whereby deferred tax assets and liabilities are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates that will be in effect for the year in which the differences are expected to affect taxable income.
	During the nine months ended September 30, 2013 and 2012, the Company recorded a provision for income taxes of $4.6 million and $4.4 million, respectively. The Company’s effective tax rate for the nine months ended September 30, 2013 and 2012 was 41.0% and 42.9%, respectively. The Company’s effective tax rate primarily reflects the statutory corporate income tax rate, the net effect of state taxes, and the effect of various permanent tax differences.

Stock_Based_Compensation

Stock Based Compensation	9 Months Ended
	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation	3. STOCK BASED COMPENSATION
	The Company maintains two stock incentive plans. The Company accounts for its stock based compensation plans using the fair-value based method for costs related to share-based payments, including stock options and restricted share units (RSUs). During the nine months ended September 30, 2013, the Company issued 80,250 RSUs with a weighted average grant date fair value of $22.02 per share, measured based on the closing fair market value of the Company’s stock on the date of grant. During the nine months ended September 30, 2012, the Company issued 73,150 RSUs with a weighted average grant date fair value of $23.13 per share, measured based on the closing fair market value of the Company’s stock on the date of grant.
	Total stock based compensation expense recorded for the three and nine months ended September 30, 2013 and 2012, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Cost of revenues (excluding depreciation and amortization)	$	22	$	11	$	61	$	32
	Product development		45		33		124		104
	Sales and marketing		45		39		124		116
	Other general and administrative		266		213		779		585
	Total stock based compensation expense	$	378	$	296	$	1,088	$	837

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]
Earnings Per Share	4. EARNINGS PER SHARE
	Basic earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Common equivalent shares, composed of incremental common shares issuable upon the exercise of stock options and restricted share units subject to vesting are included in diluted earnings per share only to the extent these shares are dilutive. The total number of common equivalent shares excluded from the calculations of diluted earnings per share, due to their anti-dilutive effect, was approximately 6,000 and 92,000 for the three and nine months ended September 30, 2013, respectively, and approximately 72,000 and 116,000 for the three and nine months ended September 30, 2012, respectively.
	The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2013 and 2012 (in thousands, except per share data):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Numerator:
	Net income	$	2,296	$	1,977	$	6,658	$	5,824
	Denominator:
	Weighted-average shares outstanding		27,085		26,173		26,716		26,100
	Effect of dilutive shares		650		1,418		882		1,376
	Weighted-average diluted shares		27,735		27,591		27,598		27,476
	Basic earnings per share	$	0.08	$	0.08	$	0.25	$	0.22
	Diluted earnings per share	$	0.08	$	0.07	$	0.24	$	0.21

Marketable_Securities

Marketable Securities	9 Months Ended
	Sep. 30, 2013
Investments Debt And Equity Securities [Abstract]
Marketable Securities	5. MARKETABLE SECURITIES
	At September 30, 2013 and December 31, 2012, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):
		September 30, 2013
		Adjusted		Unrealized		Unrealized			Fair Value
		Cost		Gains		Losses
	Level 2:
	Certificates of deposit		2,258		—		—			2,258
	Corporate debt securities		47,363		2		(31	)		47,334
	Subtotal		49,621		2		(31	)		49,592
	Total	$	49,621	$	2	$	(31	)	$	49,592
		December 31, 2012
		Adjusted		Unrealized		Unrealized			Fair Value
		Cost		Gains		Losses
	Level 1:
	Mutual funds	$	5,042	$	30	$	—		$	5,072
	Level 2:
	Certificates of deposit		2,254		—		—			2,254
	Commercial paper		3,122		1		—			3,123
	Corporate debt securities		27,017		1		(17	)		27,001
	U.S. government securities		14,499		3		—			14,502
	Subtotal		46,892		5		(17	)		46,880
	Total	$	51,934	$	35	$	(17	)	$	51,952
	The carrying amounts reported in the condensed consolidated balance sheet approximate the fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of September 30, 2013, the Company does not consider any of its marketable securities to be other than temporarily impaired. During the three months ended September 30, 2013, the Company recorded realized gains of approximately $5,000 from sales of marketable securities.

Business_Combination

Business Combination	9 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]
Business Combination	6. BUSINESS COMBINATION
	On September 9, 2013, the Company acquired substantially all of the assets of Baptist Leadership Group (BLG), a Pensacola, Florida based company that provides consulting services focused on patient-centered performance excellence in healthcare. The Company acquired BLG to strengthen its Patient Experience Solution. The consideration paid for BLG consisted of approximately $7.2 million in cash (taking into account the initial working capital adjustment that occurred at closing) and 15,230 shares of our common stock. The Company incurred approximately $110,000 in transaction costs associated with the acquisition, which were recorded in other general and administrative expense in the condensed consolidated statement of income. In allocating the purchase price, the Company has preliminarily recorded approximately $4.6 million of goodwill, $3.2 million of identifiable intangible assets, $334,000 of tangible assets, and $382,000 of liabilities. The goodwill balance is deductible for U.S. income tax purposes. The allocation of purchase price is preliminary and may be subject to change within the measurement period of one year from the acquisition date. The primary areas of the preliminary purchase price allocation that are not finalized include the composition and valuation of intangible assets, goodwill and deferred revenue. The results of operations for BLG have been included in the Company’s condensed consolidated financial statements from the date of acquisition, and are also included in the HealthStream Research segment.

Business_Segments

Business Segments	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]
Business Segments	7. BUSINESS SEGMENTS
	The Company primarily provides services to healthcare organizations and other members within the healthcare industry. The Company’s services are primarily focused on the delivery of learning and talent management products and services (HealthStream Learning & Talent Management), as well as survey and research services (HealthStream Research). The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.
	The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The following is the Company’s business segment information as of and for the three and nine months ended September 30, 2013 and 2012 (in thousands).
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
	Revenues		2013			2012			2013			2012
	Learning & Talent Management		$	26,574		$	20,341		$	74,841		$	57,444
	Research			7,085			6,039			20,383			18,450
	Total net revenue		$	33,659		$	26,380		$	95,224		$	75,894
	Income from operations
	Learning & Talent Management		$	7,355		$	6,424		$	21,685		$	17,289
	Research			755			430			1,964			1,625
	Unallocated			(4,231	)		(3,123	)		(12,491	)		(8,801	)
	Total income from operations		$	3,879		$	3,731		$	11,157		$	10,113
	Segment assets *		September 30,			December 31,
			2013			2012
	Learning & Talent Management		$	57,124		$	46,693
	Research			33,699			23,978
	Unallocated			113,978			103,857
	Total assets		$	204,801		$	174,528
	*	Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

Collaborative_Arrangement

Collaborative Arrangement	9 Months Ended
	Sep. 30, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Collaborative Arrangement	8. COLLABORATIVE ARRANGEMENT
	The Company participates in a collaborative arrangement, SimVenturesTM, with Laerdal Medical A/S (Laerdal Medical). The Company receives 50 percent of the profits or losses generated from this collaborative arrangement. For the nine months ended September 30, 2013, the Company has recorded approximately $1.8 million of revenues and $1.7 million of expenses related to the collaborative arrangement. For the nine months ended September 30, 2012, the Company recorded $1.2 million of revenues and $1.3 million of expenses related to the collaborative arrangement. The Company has also recorded approximately $0.7 million of capitalized software development for SimVentures during 2013. The financial results for this collaborative arrangement are included in the HealthStream Learning & Talent Management segment.

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income	Total stock based compensation expense recorded for the three and nine months ended September 30, 2013 and 2012, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Cost of revenues (excluding depreciation and amortization)	$	22	$	11	$	61	$	32
	Product development		45		33		124		104
	Sales and marketing		45		39		124		116
	Other general and administrative		266		213		779		585
	Total stock based compensation expense	$	378	$	296	$	1,088	$	837

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2013 and 2012 (in thousands, except per share data):
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Numerator:
	Net income	$	2,296	$	1,977	$	6,658	$	5,824
	Denominator:
	Weighted-average shares outstanding		27,085		26,173		26,716		26,100
	Effect of dilutive shares		650		1,418		882		1,376
	Weighted-average diluted shares		27,735		27,591		27,598		27,476
	Basic earnings per share	$	0.08	$	0.08	$	0.25	$	0.22
	Diluted earnings per share	$	0.08	$	0.07	$	0.24	$	0.21

Marketable_Securities_Tables

Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2013
Investments Debt And Equity Securities [Abstract]
Fair Value of Available for Sale Marketable Securities	At September 30, 2013 and December 31, 2012, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):
		September 30, 2013
		Adjusted		Unrealized		Unrealized			Fair Value
		Cost		Gains		Losses
	Level 2:
	Certificates of deposit		2,258		—		—			2,258
	Corporate debt securities		47,363		2		(31	)		47,334
	Subtotal		49,621		2		(31	)		49,592
	Total	$	49,621	$	2	$	(31	)	$	49,592
		December 31, 2012
		Adjusted		Unrealized		Unrealized			Fair Value
		Cost		Gains		Losses
	Level 1:
	Mutual funds	$	5,042	$	30	$	—		$	5,072
	Level 2:
	Certificates of deposit		2,254		—		—			2,254
	Commercial paper		3,122		1		—			3,123
	Corporate debt securities		27,017		1		(17	)		27,001
	U.S. government securities		14,499		3		—			14,502
	Subtotal		46,892		5		(17	)		46,880
	Total	$	51,934	$	35	$	(17	)	$	51,952

Business_Segments_Tables

Business Segments (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]
Business Segment Information Based on Net Revenues and Net Income from Operations	The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The following is the Company’s business segment information as of and for the three and nine months ended September 30, 2013 and 2012 (in thousands).
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
	Revenues		2013			2012			2013			2012
	Learning & Talent Management		$	26,574		$	20,341		$	74,841		$	57,444
	Research			7,085			6,039			20,383			18,450
	Total net revenue		$	33,659		$	26,380		$	95,224		$	75,894
	Income from operations
	Learning & Talent Management		$	7,355		$	6,424		$	21,685		$	17,289
	Research			755			430			1,964			1,625
	Unallocated			(4,231	)		(3,123	)		(12,491	)		(8,801	)
	Total income from operations		$	3,879		$	3,731		$	11,157		$	10,113
Business Segment Information Based on Assets
	Segment assets *		September 30,			December 31,
			2013			2012
	Learning & Talent Management		$	57,124		$	46,693
	Research			33,699			23,978
	Unallocated			113,978			103,857
	Total assets		$	204,801		$	174,528
	*	Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Tax Disclosure [Abstract]
Income tax provision	$1,629	$1,796	$4,620	$4,376
Effective tax rate			41.00%	42.90%

Stock_Based_Compensation_Addit

Stock Based Compensation - Additional Information (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans	2
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share units issued	80,250	73,150
Weighted average grant date fair value, restricted share unit	$22.02	$23.13

Stock_Based_Compensation_Stock

Stock Based Compensation - Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$378	$296	$1,088	$837
Cost of Revenues (Excluding Depreciation and Amortization) [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	22	11	61	32
Product Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	45	33	124	104
Sales and Marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	45	39	124	116
Other General and Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock based compensation expense	$266	$213	$779	$585

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]
Total number of common equivalent shares excluded from the calculations of diluted earnings per share	6,000	72,000	92,000	116,000

Earnings_Per_Share_Computation

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Numerator:
Net income	$2,296	$1,977	$6,658	$5,824
Denominator:
Weighted-average shares outstanding	27,085	26,173	26,716	26,100
Effect of dilutive shares	650	1,418	882	1,376
Weighted-average diluted shares	27,735	27,591	27,598	27,476
Basic earnings per share	$0.08	$0.08	$0.25	$0.22
Diluted earnings per share	$0.08	$0.07	$0.24	$0.21

Marketable_Securities_Fair_Val

Marketable Securities - Fair Value of Available for Sale Marketable Securities (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	$49,621	$51,934
Available for sale securities, Unrealized Gains	2	35
Available for sale securities, Unrealized Losses	-31	-17
Available for sale securities, Fair Value	49,592	51,952
Level 2 [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	49,621	46,892
Available for sale securities, Unrealized Gains	2	5
Available for sale securities, Unrealized Losses	-31	-17
Available for sale securities, Fair Value	49,592	46,880
Level 2 [Member] | Certificates of Deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	2,258	2,254
Available for sale securities, Fair Value	2,258	2,254
Level 2 [Member] | Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost	47,363	27,017
Available for sale securities, Unrealized Gains	2	1
Available for sale securities, Unrealized Losses	-31	-17
Available for sale securities, Fair Value	47,334	27,001
Level 2 [Member] | Commercial Paper [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		3,122
Available for sale securities, Unrealized Gains		1
Available for sale securities, Fair Value		3,123
Level 2 [Member] | U.S. Government Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		14,499
Available for sale securities, Unrealized Gains		3
Available for sale securities, Fair Value		14,502
Level 1 [Member] | Mutual Funds [Member]
Schedule of Available-for-sale Securities [Line Items]
Available for sale securities, Adjusted Cost		5,042
Available for sale securities, Unrealized Gains		30
Available for sale securities, Fair Value		$5,072

Marketable_Securities_Addition

Marketable Securities - Additional Information (Detail) (USD $)	3 Months Ended
	Sep. 30, 2013
Amortized Cost And Fair Value Debt Securities [Abstract]
Realized gains from sale of marketable securities	$5,000

Business_Combination_Additiona

Business Combination - Additional Information (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013
			Baptist Leadership Group [Member]
Business Acquisition [Line Items]
Acquisition date of assets of Baptist Leadership Group			9-Sep-13
Consideration paid for acquisition in cash			$7,200,000
Consideration paid for acquisition in shares			15,230
Transaction-related costs			110,000
Purchase price allocation for goodwill	34,044,000	29,299,000	4,600,000
Purchase price allocation for identifiable intangible assets			3,200,000
Purchase price allocation for net tangible assets			334,000
Purchase price allocation for liabilities			$382,000
Preliminary purchase price allocation measurement period			1 year

Business_Segments_Business_Seg

Business Segments - Business Segment Information Based on Net Revenues and Net Income from Operations (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues
Total net revenue	$33,659	$26,380	$95,224	$75,894
Income from operations
Total income from operations	3,879	3,731	11,157	10,113
Operating Segments [Member] | Learning & Talent Management [Member]
Revenues
Total net revenue	26,574	20,341	74,841	57,444
Income from operations
Total income from operations	7,355	6,424	21,685	17,289
Operating Segments [Member] | Research [Member]
Revenues
Total net revenue	7,085	6,039	20,383	18,450
Income from operations
Total income from operations	755	430	1,964	1,625
Unallocated [Member]
Income from operations
Total income from operations	($4,231)	($3,123)	($12,491)	($8,801)

Business_Segments_Business_Seg1

Business Segments - Business Segment Information Based on Assets (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Segment Reporting Information [Line Items]
Total assets	$204,801	$174,528
Operating Segments [Member] | Learning & Talent Management [Member]
Segment Reporting Information [Line Items]
Total assets	57,124	46,693
Operating Segments [Member] | Research [Member]
Segment Reporting Information [Line Items]
Total assets	33,699	23,978
Unallocated [Member]
Segment Reporting Information [Line Items]
Total assets	$113,978	$103,857

Collaborative_Arrangement_Addi

Collaborative Arrangement - Additional Information (Detail) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Payments associated with capitalized software development	$3,017,000	$3,097,000
Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Profits or losses received from collaborative arrangement	50.00%
Revenues related to collaborative arrangement	1,800,000	1,200,000
Expenses related to collaborative arrangement	1,700,000	1,300,000
Collaborative Arrangement [Member] | SimVentures [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Payments associated with capitalized software development	$700,000